{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:54Z","timestamp":1771002174437,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/nrneph.2009.71","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T08:41:26Z","timestamp":1240908086000},"page":"349-354","source":"Crossref","is-referenced-by-count":7,"title":["Unusual renal presentation of Fabry disease in a female patient"],"prefix":"10.1038","volume":"5","author":[{"given":"Cataldo","family":"Abaterusso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"De Biase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Salviati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Millardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Tomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Bernich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"BFnrneph200971_CR1","first-page":"227","volume":"48","author":"P Asthon-Prolla","year":"2000","unstructured":"Asthon-Prolla, P.  et al. Fabry disease: Twenty-two novel mutations in the \u03b1-galactosidase A gene and genotype\/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. J. Invest. Med. 48, 227\u2013235 (2000).","journal-title":"J. Invest. Med."},{"key":"BFnrneph200971_CR2","first-page":"3733","volume-title":"\u03b1-galactosidase A deficiency: Fabry disease in The Metabolic and Molecular Basis of Inherited Disease","author":"R Desnick","year":"2001","unstructured":"Desnick, R., Ioannou, Y. A. & Eng, C. M. \u03b1-galactosidase A deficiency: Fabry disease in The Metabolic and Molecular Basis of Inherited Disease (eds Scriver, C.  et al.) 3733\u20133774 (New York, McGraw Hill, 2001)."},{"key":"BFnrneph200971_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot, K. D., Holmes, A. & Miners, A. H. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J. Med. Genet. 38, 769\u2013775 (2001).","journal-title":"J. Med. Genet."},{"key":"BFnrneph200971_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"CM Eng","year":"2007","unstructured":"Eng, C. M.  et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J. Inherit Metab. Dis. 30, 184\u2013192 (2007).","journal-title":"J. Inherit Metab. Dis."},{"key":"BFnrneph200971_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","volume":"9","author":"RY Wang","year":"2007","unstructured":"Wang, R. Y., Lelis, A., Mirocha, J. & Wilcox, W. R. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet. Med. 9, 34\u201345 (2007).","journal-title":"Genet. Med."},{"key":"BFnrneph200971_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"PB Deegan","year":"2006","unstructured":"Deegan, P. B.  et al. Natural history of Fabry disease in females in the Fabry Outcome Survey. J. Med. Genet. 43, 347\u2013352 (2006).","journal-title":"J. Med. Genet."},{"key":"BFnrneph200971_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","volume":"162","author":"M Ries","year":"2003","unstructured":"Ries, M.  et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur. J. Pediatr. 162, 767\u2013772 (2003).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrneph200971_CR8","first-page":"109","volume":"15","author":"A Sessa","year":"2002","unstructured":"Sessa, A.  et al. Renal ultrastructural findings in Anderson-Fabry disease. J. Nephrol. 15, 109\u2013112 (2002).","journal-title":"J. Nephrol."},{"key":"BFnrneph200971_CR9","first-page":"7","volume":"34","author":"M Elleder","year":"1998","unstructured":"Elleder, M., Poup\u011btov\u00e1, H. & Kozich, V. Fetal pathology in Fabry's disease and mucopolysaccharidosis type I. Cesk. Patol. 34, 7\u201312 (1998).","journal-title":"Cesk. Patol."},{"key":"BFnrneph200971_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","volume":"51","author":"C T\u00f8\u00f3ndel","year":"2008","unstructured":"T\u00f8\u00f3ndel, C., Bostad, L., Hirth, A. & Svarstad, E. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am. J. Kidney Dis. 51, 767\u2013776 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph200971_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton, M. H.  et al. Natural history of Fabry renal disease: influence of \u03b1-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 81, 122\u2013138 (2002).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph200971_CR12","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz, A.  et al. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol. Dial. Transplant. 23, 1600\u20131607 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph200971_CR13","volume-title":"\u03b1-Galactosidase A deficiency in Oxford Textbook of Clinical Nephrology","author":"RJ Desnick","year":"2004","unstructured":"Desnick, R. J. \u03b1-Galactosidase A deficiency in Oxford Textbook of Clinical Nephrology 3rd edn (eds Davison, A. M.  et al.) (Oxford University Press, Oxford, 2004)."},{"key":"BFnrneph200971_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ki.1978.32","volume":"13","author":"M Gubler","year":"1978","unstructured":"Gubler, M.  et al. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int. 13, 223\u2013235 (1978).","journal-title":"Kidney Int."},{"key":"BFnrneph200971_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00428-007-0456-x","volume":"451","author":"M Takao","year":"2007","unstructured":"Takao, M.  et al. Postmortem diagnosis of Fabry disease with acromegaly and a unique vasculopathy. Virchows Arch. 451, 721\u2013727 (2007).","journal-title":"Virchows Arch."},{"key":"BFnrneph200971_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00428-005-0089-x","volume":"448","author":"R Schiffmann","year":"2006","unstructured":"Schiffmann, R.  et al. Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch. 448, 337\u2013343 (2006).","journal-title":"Virchows Arch."},{"key":"BFnrneph200971_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10545-006-0340-x","volume":"29","author":"RJ Kalliokoski","year":"2006","unstructured":"Kalliokoski, R. J.  et al. Structural and functional changes in peripheral vasculature of Fabry patients. J. Inherit. Metab. Dis. 29, 660\u2013666 (2006).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnrneph200971_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1440-0960.2007.00326.x","volume":"48","author":"L Martin","year":"2007","unstructured":"Martin, L., Sturgess, A., Sillence, D. & Murrell, D. F. Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparaesthesia. Australas. J. Dermatol. 48, 40\u201342 (2007).","journal-title":"Australas. J. Dermatol."},{"key":"BFnrneph200971_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ncpneph0806","volume":"4","author":"A Ortiz","year":"2008","unstructured":"Ortiz, A.  et al. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults. Nat. Clin. Pract. Nephrol. 4, 327\u2013336 (2008).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"BFnrneph200971_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng, C. M.  et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet. Med. 8, 539\u2013548 (2006).","journal-title":"Genet. Med."},{"key":"BFnrneph200971_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","volume":"146","author":"M Banikazemi","year":"2007","unstructured":"Banikazemi, M.  et al. Agalsidase-\u03b2 therapy for advanced Fabry disease: a randomized trial. Ann. Intern. Med. 146, 77\u201386 (2007).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph200971_CR22","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1681\/ASN.2006121400","volume":"18","author":"H Tahir","year":"2007","unstructured":"Tahir, H., Jackson, L. L. & Warnock, D. G. Antiproteinuric therapy and Fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-\u03b2. J. Am. Soc. Nephrol. 18, 2609\u20132617 (2007).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.71","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:32:44Z","timestamp":1684470764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2009.71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnrneph200971"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2009.71","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}